Fenwick represented Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, in its $20 million Series A round of financing led by Bow Capital and joined by Andreessen Horowitz, which led its $5 million seed round. Other investors in the funding round included 50Y, DCVC, Stanford University and angel investors, including Google’s head of AI Jeff Dean.
The new funding will allow Deepcell to develop its microfluidics-based technology, continue building a cell morphology atlas of more than 400 million cells and drive a hypothesis-free approach to cell classification and sorting. More information can be obtained from Deepcell’s announcement.
The Fenwick transaction team included partners Michael Esquivel and Stefano Quintini, counsel Malcolm Katz and associates Noah Johnson and Shajee Rizvi.